Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer’s Disease Neuroimaging Initiative cohort

2 Apr 2024

Abstract excerpt

Abstract Alzheimer's disease (AD) is a neurodegenerative disease that commonly causes dementia. Identifying biomarkers for the early detection of AD is an emerging need, as brain dysfunction begins two decades before the onset of clinical symptoms. To this end, we reanalyzed untargeted metabolomic mass spectrometry data from 905 patients enrolled in the AD Neuroimaging Initiative (ADNI) cohort using MS-DIAL, with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Metabolomics and Mass Spectrometry Studies
Share to Tryptophan and brain disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38565541
DOI: 10.1038/s41598-024-56837-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer’s Disease Neuroimaging Initiative cohortPMID 38565541Read ↗

Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer’s Disease Neuroimaging Initiative cohortSemantic proximity Read ↗

A seven-year longitudinal study of the Alzheimer’s disease blood metabolomeSemantic proximity Read ↗

Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer disease brainsSemantic proximity Read ↗

Differences in Plasma Metabolites Related to Alzheimer’s Disease, APOE-ε4 status and EthnicitySemantic proximity Read ↗

Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer's disease brains.Semantic proximity Read ↗

The blood metabolome of cognitive function and brain health in middle-aged adults – influences of genes, gut microbiome, and exposomeSemantic proximity Read ↗

Sex Differences in the Metabolome of Alzheimer's Disease ProgressionSemantic proximity Read ↗

Integrated analysis of genomics, longitudinal metabolomics, and Alzheimer's risk factors among 1,111 cohort participantsSemantic proximity Read ↗

Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics.Semantic proximity Read ↗

Integrative metabolomics‐genomics approach reveals key metabolic pathways and regulators of Alzheimer's diseaseSemantic proximity Read ↗

Alteration of Metabolic Profile During the Progression of Alzheimer’s DiseaseSemantic proximity Read ↗

CSF metabolites associated with biomarkers of Alzheimer’s disease pathologySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.